| Schedule of outstanding shares of common stock equivalents were excluded from the computation of diluted earnings per share |
The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share of common stock for the periods presented because including them would have been anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, (Unaudited) |
|
Nine Months Ended
September 30, (Unaudited) |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
| Stock options |
23,490,000 |
|
|
25,000,678 |
|
|
23,490,000 |
|
|
25,000,678 |
|
| Common shares underlying convertible debt |
5,303,591 |
|
|
5,215,457 |
|
|
5,303,591 |
|
|
5,215,457 |
|
| Warrants |
133,945,796 |
|
|
145,336,155 |
|
|
134,917,225 |
|
|
22,304,750 |
|
|
| Schedule of earnings per share, basic and diluted |
The computations of basic and diluted net loss per common share are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, (Unaudited) |
|
Nine Months Ended
September 30, (Unaudited) |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
| Basic net loss per share: |
|
|
|
|
|
|
|
| Net loss |
$ |
(1,824,818) |
|
|
$ |
(1,296,696) |
|
|
$ |
(6,009,362) |
|
|
$ |
(5,058,592) |
|
| Weighted average common shares outstanding – basic |
413,489,603 |
|
|
256,758,472 |
|
|
376,547,498 |
|
|
207,536,173 |
|
| Net loss per share - basic |
$ |
—
|
|
|
$ |
(0.01) |
|
|
$ |
(0.02) |
|
|
$ |
(0.02) |
|
|
|
|
|
|
|
|
|
| Diluted net loss per share: |
|
|
|
|
|
|
|
| Net loss (as adjusted) |
$ |
(1,704,980) |
|
|
$ |
(1,720,835) |
|
|
$ |
(6,009,362) |
|
|
$ |
(5,401,484) |
|
| Weighted average common shares outstanding – diluted |
414,461,032 |
|
|
257,255,653 |
|
|
376,547,498 |
|
|
208,434,966 |
|
| Net loss per share - diluted |
$ |
—
|
|
|
$ |
(0.01) |
|
|
$ |
(0.02) |
|
|
$ |
(0.03) |
|
|